Condensed consolidating financial statements (Tables)

3 Months Ended

Mar. 31, 2016

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Condensed Consolidating Statements of Income

	DaVita						Non-
	HealthCare			Guarantor			Guarantor			Consolidating			Consolidated
For the three months ended March 31, 2016	Partners Inc.			subsidiaries			subsidiaries			adjustments			total
Patient service revenues	$	—		$	1,653,312		$	863,842		$	(39,416	)	$	2,477,738
Less: Provision for uncollectible accounts		—			(58,813	)		(50,392	)		—			(109,205	)
Net patient service revenues		—			1,594,499			813,450			(39,416	)		2,368,533
Capitated revenues		—			467,001			420,173			(127	)		887,047
Other revenues		186,975			485,316			31,716			(378,451	)		325,556
Total net revenues		186,975			2,546,816			1,265,339			(417,994	)		3,581,136
Operating expenses		122,273			2,377,630			1,134,338			(417,994	)		3,216,247
Operating income		64,702			169,186			131,001			—			364,889
Debt expense, including debt refinancing charges		(101,101	)		(92,173	)		(11,514	)		101,904			(102,884	)
Other income		98,560			4,336			1,984			(101,904	)		2,976
Income tax expense		35,146			73,254			18,422			—			126,822
Equity earnings in subsidiaries		70,419			62,324			—			(132,743	)		—
Net income		97,434			70,419			103,049			(132,743	)		138,159
Less: Net income attributable to noncontrolling interests		—			—			—			(40,725	)		(40,725	)
Net income attributable to DaVita HealthCare Partners Inc.	$	97,434		$	70,419		$	103,049		$	(173,468	)	$	97,434

	DaVita						Non-
	HealthCare			Guarantor			Guarantor			Consolidating			Consolidated
For the three months ended March 31, 2015	Partners Inc.			subsidiaries			subsidiaries			adjustments			total
Patient service revenues	$	—		$	1,581,959		$	723,843		$	(33,987	)	$	2,271,815
Less: Provision for uncollectible accounts		—			(64,077	)		(35,087	)		—			(99,164	)
Net patient service revenues		—			1,517,882			688,756			(33,987	)		2,172,651
Capitated revenues		—			447,338			403,124			53			850,515
Other revenues		168,265			411,028			6,312			(320,806	)		264,799
Total net revenues		168,265			2,376,248			1,098,192			(354,740	)		3,287,965
Operating expenses		123,769			2,597,953			985,139			(354,740	)		3,352,121
Operating income (loss)		44,496			(221,705	)		113,053			—			(64,156	)
Debt expense, including debt refinancing charges		(95,478	)		(85,783	)		(9,286	)		93,155			(97,392	)
Other income		91,023			53			1,546			(93,155	)		(533	)
Income tax expense (benefit)		17,514			(129,235	)		25,788			—			(85,933	)
Equity (loss) earnings in subsidiaries		(133,144	)		45,056			—			88,088			—
Net (loss) income		(110,617	)		(133,144	)		79,525			88,088			(76,148	)
Less: Net income attributable to noncontrolling interests		—			—			—			(34,469	)		(34,469	)
Net (loss) income attributable to DaVita HealthCare Partners Inc.	$	(110,617	)	$	(133,144	)	$	79,525		$	53,619		$	(110,617	)

Condensed Consolidating Statements of Comprehensive Income

	DaVita					Non-
	HealthCare			Guarantor		Guarantor		Consolidating			Consolidated
For the three months ended March 31, 2016	Partners Inc.			subsidiaries		subsidiaries		adjustments			total
Net income	$	97,434		$	70,419	$	103,049	$	(132,743	)	$	138,159
Other comprehensive (loss) income		(4,868	)		—		11,181		—			6,313
Total comprehensive income		92,566			70,419		114,230		(132,743	)		144,472
Less: comprehensive income attributable to the noncontrolling interests		—			—		—		(40,725	)		(40,725	)
Comprehensive income attributable to DaVita HealthCare Partners Inc.	$	92,566		$	70,419	$	114,230	$	(173,468	)	$	103,747

	DaVita						Non-
	HealthCare			Guarantor			Guarantor			Consolidating			Consolidated
For the three months ended March 31, 2015	Partners Inc.			subsidiaries			subsidiaries			adjustments			total
Net (loss) income	$	(110,617	)	$	(133,144	)	$	79,525		$	88,088		$	(76,148	)
Other comprehensive loss		(4,723	)		—			(17,885	)		—			(22,608	)
Total comprehensive (loss) income		(115,340	)		(133,144	)		61,640			88,088			(98,756	)
Less: comprehensive income attributable to the noncontrolling interests		—			—			—			(34,469	)		(34,469	)
Comprehensive (loss) income attributable to DaVita HealthCare Partners Inc.	$	(115,340	)	$	(133,144	)	$	61,640		$	53,619		$	(133,225	)

Condensed Consolidating Balance Sheets

	DaVita				Non-
	HealthCare		Guarantor		Guarantor		Consolidating			Consolidated
As of March 31, 2016	Partners Inc.		subsidiaries		subsidiaries		adjustments			total
Cash and cash equivalents	$	667,109	$	73,221	$	301,097	$	—		$	1,041,427
Accounts receivable, net		—		937,747		917,538		—			1,855,285
Other current assets		408,369		792,812		101,667		—			1,302,848
Total current assets		1,075,478		1,803,780		1,320,302		—			4,199,560
Property and equipment, net		270,106		1,555,802		1,085,297		—			2,911,205
Amortizable intangibles, net		660		1,596,973		81,074		—			1,678,707
Investments in subsidiaries		9,019,776		2,020,158		—		(11,039,934	)		—
Intercompany receivables		3,797,849		—		697,353		(4,495,202	)		—
Other long-term assets and investments		67,725		55,403		115,970		—			239,098
Goodwill		—		7,753,168		1,732,460		—			9,485,628
Total assets	$	14,231,594	$	14,785,284	$	5,032,456	$	(15,535,136	)	$	18,514,198
Current liabilities	$	236,695	$	1,686,198	$	520,725	$	—		$	2,443,618
Intercompany payables		—		2,889,630		1,605,572		(4,495,202	)		—
Long-term debt and other long-term liabilities		8,713,321		1,189,680		333,142		—			10,236,143
Noncontrolling interests subject to put provisions		577,652		—		—		335,053			912,705
Total DaVita HealthCare Partners Inc. shareholders’ equity		4,703,926		9,019,776		2,020,158		(11,039,934	)		4,703,926
Noncontrolling interests not subject to put provisions		—		—		552,859		(335,053	)		217,806
Total equity		4,703,926		9,019,776		2,573,017		(11,374,987	)		4,921,732
Total liabilities and equity	$	14,231,594	$	14,785,284	$	5,032,456	$	(15,535,136	)	$	18,514,198

	DaVita				Non-
	HealthCare		Guarantor		Guarantor		Consolidating			Consolidated
As of December 31, 2015	Partners Inc.		subsidiaries		subsidiaries		adjustments			total
Cash and cash equivalents	$	1,186,636	$	109,357	$	203,123	$	—		$	1,499,116
Accounts receivable, net		—		929,390		794,838		—			1,724,228
Other current assets		431,504		769,947		78,485		—			1,279,936
Total current assets		1,618,140		1,808,694		1,076,446		—			4,503,280
Property and equipment, net		268,066		1,575,890		944,784		—			2,788,740
Intangible assets, net		540		1,634,920		51,866		—			1,687,326
Investments in subsidiaries		8,893,079		1,597,185		—		(10,490,264	)		—
Intercompany receivables		3,474,133		—		701,814		(4,175,947	)		—
Other long-term assets and investments		74,458		53,346		113,246		—			241,050
Goodwill		—		7,834,257		1,460,222		—			9,294,479
Total assets	$	14,328,416	$	14,504,292	$	4,348,378	$	(14,666,211	)	$	18,514,875
Current liabilities	$	185,217	$	1,730,123	$	483,798	$	—		$	2,399,138
Intercompany payables		—		2,750,102		1,425,845		(4,175,947	)		—
Long-term debt and other long-term liabilities		8,730,673		1,130,988		305,838		—			10,167,499
Noncontrolling interests subject to put provisions		541,746		—		—		322,320			864,066
Total DaVita HealthCare Partners Inc. shareholders' equity		4,870,780		8,893,079		1,597,185		(10,490,264	)		4,870,780
Noncontrolling interests not subject to put provisions		—		—		535,712		(322,320	)		213,392
Total equity		4,870,780		8,893,079		2,132,897		(10,812,584	)		5,084,172
Total liabilities and equity	$	14,328,416	$	14,504,292	$	4,348,378	$	(14,666,211	)	$	18,514,875

Condensed Consolidating Statements of Cash Flows

	DaVita						Non-
	HealthCare			Guarantor			Guarantor			Consolidating			Consolidated
For the three months ended March 31, 2016	Partners Inc.			subsidiaries			subsidiaries			adjustments			total
Cash flows from operating activities:
Net income	$	97,434		$	70,419		$	103,049		$	(132,743	)	$	138,159
Changes in operating assets and liabilities and non-cash items included in net income		(18,699	)		217,405			(40,606	)		132,743			290,843
Net cash provided by operating activities		78,735			287,824			62,443			—			429,002
Cash flows from investing activities:
Additions of property and equipment, net		(16,865	)		(86,055	)		(70,267	)		—			(173,187	)
Acquisitions		—			(400,093	)		(5,061	)		—			(405,154	)
Proceeds from asset and business sales		—			4,657			—			—			4,657
(Purchases) proceeds from investment sales and other items		23,387			(7,438	)		3,424			—			19,373
Net cash provided by (used in) investing activities		6,522			(488,929	)		(71,904	)		—			(554,311	)
Cash flows from financing activities:
Long-term debt and related financing costs, net		(21,247	)		(1,977	)		(1,347	)		—			(24,571	)
Intercompany borrowing (payments)		(315,986	)		167,702			148,284			—			—
Other items		(267,551	)		(756	)		(40,219	)		—			(308,526	)
Net cash provided by (used in) financing activities		(604,784	)		164,969			106,718			—			(333,097	)
Effect of exchange rate changes on cash		—			—			717			—			717
Net (decrease) increase in cash and cash equivalents		(519,527	)		(36,136	)		97,974			—			(457,689	)
Cash and cash equivalents at beginning of period		1,186,636			109,357			203,123			—			1,499,116
Cash and cash equivalents at end of period	$	667,109		$	73,221		$	301,097		$	—		$	1,041,427

	DaVita						Non-
	HealthCare			Guarantor			Guarantor			Consolidating			Consolidated
For the three months ended March 31, 2015	Partners Inc.			subsidiaries			subsidiaries			adjustments			total
Cash flows from operating activities:
Net (loss) income	$	(110,617	)	$	(133,144	)	$	79,525		$	88,088		$	(76,148	)
Changes in operating assets and liabilities and non-cash items included in net income		154,352			410,880			9,093			(88,088	)		486,237
Net cash provided by operating activities		43,735			277,736			88,618			—			410,089
Cash flows from investing activities:
Additions of property and equipment, net		(6,230	)		(48,802	)		(66,389	)		—			(121,421	)
Acquisitions		—			(40,018	)		(632	)		—			(40,650	)
Proceeds from asset and business sales		—			2,565			—			—			2,565
Purchases/proceeds from investment sales and other items		(84,640	)		(537	)		(7,604	)		—			(92,781	)
Net cash used in investing activities		(90,870	)		(86,792	)		(74,625	)		—			(252,287	)
Cash flows from financing activities:
Long-term debt and related financing costs, net		(21,250	)		(3,620	)		(3,569	)		—			(28,439	)
Intercompany borrowing (payments)		180,207			(202,804	)		22,597			—			—
Other items		(56,828	)		—			(25,601	)		—			(82,429	)
Net cash provided by (used in) financing activities		102,129			(206,424	)		(6,573	)		—			(110,868	)
Effect of exchange rate changes on cash		—			—			(904	)		—			(904	)
Net increase (decrease) in cash and cash equivalents		54,994			(15,480	)		6,516			—			46,030
Cash and cash equivalents at beginning of period		698,876			77,921			188,444			—			965,241
Cash and cash equivalents at end of period	$	753,870		$	62,441		$	194,960		$	—		$	1,011,271